Frontage Holdings Corporation has announced a change in its management effective July 15, 2025. Mr. Jun (Henry) Gao will resign from his position as Chief Financial Officer, and Ms. Huan Wang will step in as the interim Chief Financial Officer. Ms. Wang, who has significant experience in finance within the pharmaceutical and CRO industry, is currently the Vice President Finance of Frontage Laboratories, Inc., a wholly owned subsidiary of the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Frontage Holdings Corporation published the original content used to generate this news brief on July 14, 2025, and is solely responsible for the information contained therein.